SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Shire plc – ‘8-K’ for 11/25/15 – EX-10.02

On:  Monday, 11/30/15, at 9:08am ET   ·   For:  11/25/15   ·   Accession #:  950103-15-9167   ·   File #:  0-29630

Previous ‘8-K’:  ‘8-K’ on / for 11/23/15   ·   Next:  ‘8-K’ on / for 12/1/15   ·   Latest:  ‘8-K’ on / for 1/11/19

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

11/30/15  Shire plc                         8-K:1,9    11/25/15    3:111K                                   Davis Polk & … LLP 01/FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     13K 
 2: EX-10.01    Material Contract                                   HTML     27K 
 3: EX-10.02    Material Contract                                   HTML     14K 


EX-10.02   —   Material Contract


This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



Exhibit 10.02

 

 

  5 The North Colonnade
  Canary Wharf
  London E14 4BB
  United Kingdom
   
PRIVATE AND CONFIDENTIAL Tel    +44 (0)20 7623 2323
   
Shire plc (the “Company”)  
5 Riverwalk barclays.com
Citywest Business Campus  
Dublin 24  
Ireland  

 

For the attention of: Thomas Greene

 

20th November 2015

 

SHIRE PLC - CONSENT REQUEST APPROVAL NOTICE

 

1.We refer to:

 

(A)the US$2,100,000,000 multicurrency revolving and swingline facilities agreement dated 12 December 2014 between, among others, the Company as an Original Borrower and an Original Guarantor and Barclays Bank PLC as Facility Agent (the “Facilities Agreement”); and

 

(B)your letter to us dated 4 November 2015 in which you requested that the Majority Lenders agree to amendments of certain provisions of the Facilities Agreement (the “Consent Request”).

 

2.Unless otherwise defined, terms and expressions defined in the Facilities Agreement or in the Consent Request shall have the same meaning when used in this letter.

 

3.We confirm that we have received the consent of the Majority Lenders to the First Requested Amendment and the Second Requested Amendment (the “Approved Amendments”) and consequently that the Approved Amendments shall, provided that you and the other Obligors sign, date and return to us a copy of this letter in accordance with paragraph 1.3 of the Consent Request, become effective immediately and automatically, and from that date the Facilities Agreement and the Consent Request shall be read and construed as one document to the extent of the Approved Amendments.

 

4.Please confirm your agreement to the terms of this letter by signing, dating and returning a copy thereof.

 

5.This letter may be executed in any number of counterparts and this has the same effect as if the signatures on the counterparts were on a single copy of this letter.

 

6.This letter is a Finance Document.

 

7.The provisions of clause 46 (Governing law) and clause 47 (Enforcement) of the Facilities Agreement are incorporated into this letter as though they were set out in full, except that references to the Facilities Agreement are to be construed as references to this letter.

 

Yours faithfully

 

/s/ Chris Ketchen

for and on behalf of
Barclays Bank PLC
as Facility Agent, for itself and on behalf of each of the Finance Parties

 

 

 

Barclays Bank PLC, Authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority
Registered in England, Registered No. 1026167, Registered office: 1 Churchill Place, London E14 5HP  

2

 

SHIRE PLC CONSENT REQUEST APPROVAL NOTICE SIGNATURE PAGE

 

 

Acknowledged and agreed

 

 

 

/s/ Jeff Poulton

for and on behalf of
Shire plc

 

 

 

/s/ Tom Greene

for and on behalf of
Shire Global Finance

 

 

 

/s/ Tom Greene

for and on behalf of
Shire Biopharmaceuticals Holdings

 

 

 

/s/ Leo de Waal

for and on behalf of
Shire Holdings Europe No. 2 S.à r.l.

 

 

 

/s/ Leo de Waal

for and on behalf of
Shire Holdings Luxembourg S.à r.l.

 

 

 

/s/ Michael Garry

for and on behalf of
Shire Pharmaceutical Holdings Ireland Limited

 

 

 

 

 

Date: 25th November 2015 532294668

 

 

 

Top
Filing Submission 0000950103-15-009167   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 4:43:45.1am ET